DA YU FIN (01073) announced a delightful profit surge, with an expected annual net profit after tax of approximately HK$37 million, a year-on-year increase.

16:43 06/03/2026

Dayu Financial (01073) has released an announcement. The board of directors of the company expects that the group's tax-exempt net profit for the fiscal year ending on December 31, 2025 will be approximately 37 million Hong Kong dollars, compared to approximately 23 million Hong Kong dollars for the fiscal year ending on December 31, 2024.

DA YU FIN (01073) announced that the Board of Directors expects the Group to achieve a post-tax net profit of approximately HK$37 million for the year ending December 31, 2025, compared to approximately HK$23 million for the year ending December 31, 2024. Despite higher non-cash impairment provision compared to the previous year, the post-tax net profit for the year ending December 31, 2025 is expected to increase, primarily due to an increase in bond investment income and asset management fee income.

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

CICC: Maintain "Buy" rating on HANSOH PHARMA (03692), raise target price to HK$46.41

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

CICC: Maintain "Buy" rating on HANSOH PHARMA (03692), raise target price to HK$46.41